Mission BioCapital VI LP

Amendment
CIK: 0002039280·Pooled Investment Fund·DELAWARE·Filed: Sep 26, 2025
Total Offering

Indefinite

Amount Sold

$133,750,000

Investors

9

First Sale

Sep 30, 2024

Offering Details

Type
Pooled Investment Fund
Exemptions
Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7)
Entity Type
Limited Partnership
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
General Partner Mission BioCapital VI GP LLC
Related Person
Peter D. Parker
Related Person

Company

Mission BioCapital VI LP

139 MAIN STREET, SUITE 401

CAMBRIDGE, MA, 02142

617-276-5578

SEC Filing

0002039280-25-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free